IGF1 and metabolic syndrome: Insulin resistance, a key feature of metabolic syndrome, results in compensatory hyperinsulinemia, increased IGF-1 secretion, and reduced levels of sex hormone-binding globulin (SHBG), thereby increasing free androgen bioavailability and amplifying inflammatory pathways [28].